Teva Fights To Invalidate Bayer Patent Over Testosterone Drug
Generic-drug maker Teva Pharmaceuticals is suing rival Bayer to invalidate its patent over a testosterone supplement, arguing that the injectable hormone treatment is not inventive or novel....To view the full article, register now.
Already a subscriber? Click here to view full article